Clinical Trial Update: A Prospective, Open-labeled, Multi-centric Trial in Subjects With Systolic Heart Failure to Evaluate Bisoprolol Treatment for the Effects on Surrogate Markers of Heart Failure in Korea [Phase 4]

View source ↗

Summary

A prospective open-label Phase 4 trial in Korea assessed bisoprolol's effects on surrogate markers of heart failure in patients with systolic heart failure; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Bisoprolol (Bisoprolol)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Heart Failure, Congestive | Phase 4 | Status: COMPLETED | Results posted: 2014-02-14